Welcome to the April A to Z Blogging Challenge! Every year, bloggers from around the world commit to posting every day in April (except Sundays), working through the alphabet one letter at a time. This year, I’m visiting twenty-six fictional alternate Earths — worlds that diverged from our own at some crucial moment and became something wonderfully, unsettlingly different. Think of it like the TV show Sliders, which followed a group of travelers “sliding” between parallel dimensions, never quite knowing what version of Earth they’d land on next. Each day, we visit a new one. Today: I.

---

The first thing you notice, sliding into Immortality Earth, is the waiting room.

Not any specific waiting room — although you will, if you stay long enough, encounter plenty of those. What you notice is that the entire world has the quality of one. People sitting. People waiting. Not unhappily, exactly, but with a particular stillness that you will come to recognize as the signature affect of a civilization that stopped being in a hurry sometime around 2015 and has not found a compelling reason to resume. There is no urgency here. There is, in its place, a kind of vast, comfortable, faintly oppressive patience.

This makes sense, once you understand what happened.

The Accident (1994)

Her name was Dr. Yun-seo Chae, and she was not trying to cure death. She was trying to cure lupus.

This is the part of the story that Immortality Earth cannot quite decide how to tell. In the early years, the tendency was hagiography — murals, commemorative stamps, a biopic that won three Academy Awards and featured a memorable scene of Chae standing in her lab at 2 a.m., backlit, holding up a vial, the music swelling. The current tendency, particularly among the generation born after 1994 and increasingly crowded off the planet by everyone who came before them, leans toward something more complicated. A revisionism that is not quite blame — no one can quite bring themselves to blame a woman who was trying to help people with an autoimmune disease — but is at least a sustained, searching look at the question of whether “accident” fully captures what happened.

What happened, in the technical sense, is this: Chae, working at a mid-sized research university in Seoul, was investigating the role of telomerase in immune cell regulation. Telomerase is the enzyme responsible for maintaining the protective caps on chromosomes — the telomeres — that shorten with each cell division and whose progressive shortening is one of the primary mechanisms of cellular aging. Chae’s hypothesis was that abnormal telomerase activity was contributing to the runaway immune responses characteristic of lupus. She was not wrong about this. She was also, while developing a compound intended to modulate that activity, not anticipating what would happen when her delivery mechanism — a modified retroviral vector — proved considerably more promiscuous than her models predicted.

The compound worked. The immune dysregulation in her test subjects resolved. The subjects also, as a secondary effect that Chae spent three increasingly sleepless weeks trying to convince herself she was misreading, stopped aging.

Not slowed. Stopped.

The telomeres weren’t just stabilized. They were, in the presence of the compound, actively maintained — rebuilt after each division, indefinitely, by a mechanism that Chae’s team spent the next four years trying to fully characterize and never quite did. The cells divided. The telomeres held. The organism, in every measurable way, ceased to accumulate the damage that constitutes biological aging.

Chae published. The world, as worlds do when presented with something genuinely unprecedented, first ignored it, then disputed it, then replicated it, then spent eighteen months in a state of collective hyperventilation, and then — more quickly than almost anyone had predicted — administered it to approximately 340 million people before the first serious policy frameworks existed to ask whether it should.

The compound was cheap to synthesize. It was stable. A single course of treatment was sufficient. Within four years of publication, it was available over the counter in seventeen countries. Within eight, it was in the municipal water supply of two cities in the American Midwest, administered by local governments that had decided not to wait for federal guidance that showed no signs of arriving.

By 2003, the majority of the world’s population had received the treatment.

By 2010, the implications of this were beginning, in the way of very large and slow-moving things, to arrive.

What Immortality Actually Means (A Partial List)

A clarification, because language matters here: the compound does not make you indestructible. People on Immortality Earth still die. They die in accidents. They die of cancer, which telomere stabilization does not prevent and in some early-model recipients slightly exacerbated before the formulation was corrected. They die of infectious disease, of violence, of the various misfortunes that have always been available to human beings who live in a physical world with other human beings in it.

What they do not do is grow old and die of that.

The distinction sounds like it should be comforting. It is, instead, mostly clarifying. What the compound eliminated was not death but the specific structure that death used to give to a human life. The arc. The shape. The knowledge, previously reliable, that you had a limited time and that this limitation had implications for what you chose to do with it.

That structure, it turns out, was doing a lot of work that nobody had fully appreciated until it was gone.

The Numbers Problem

Immortality Earth’s population, as of the current year, is approximately 14.2 billion people. It was 7.8 billion in 2003, which is when the majority of the world received the treatment, and it has been growing since without the natural attrition that previously kept the curve manageable.

People still have children. This surprised demographers, who had theorized that immortals would reduce reproduction given the logic that the primary evolutionary drive toward having children is the continuation of the species in the face of individual mortality, and that removal of the mortality variable would reduce the drive. The demographers were wrong, because evolutionary drives are not primarily logical and also because people simply like having children, mortality or not.

The result is a planet accommodating nearly twice the population it was designed, in terms of infrastructure, food systems, and physical space, to support. Urban density in major cities has reached numbers that would be, on our Earth, associated with disaster conditions and are here simply associated with Tuesday. Agricultural land has been expanded into territories previously considered marginal. The oceans are being farmed with an intensity that the marine biology community describes, in its publications, with the careful measured language of people who are very frightened and trying to remain professional about it.

Housing costs, across virtually every major market on Immortality Earth, are the dominant political issue of the past twenty years, have been the subject of more legislation than any other topic, and have not improved. The math is not complicated: the supply of land is fixed, the number of people who need to live on it is not, and no amount of zoning reform addresses the root variable.

The root variable is not something that any elected government has yet found a politically viable way to address.

The Career Problem (Or: The Reason Your Boss Has Been Your Boss Since Before You Were Born)

On our Earth, organizations are shaped by mortality. People retire. People die. The generation ahead of you eventually moves on, and in moving on creates the space — the promotions, the opportunities, the simple breathing room — that allows the generation behind them to advance.

On Immortality Earth, this does not happen.

The executive who was in her position when the treatment became universal in 2003 is, if she has managed to avoid the non-aging-related causes of death, still in her position. The professor with tenure in 1998 has tenure now. The politician first elected in 1996 has had, barring electoral defeat, a continuous unbroken career of nearly thirty years with no biological reason to stop, and increasing institutional knowledge and name recognition to deploy against anyone who might prefer that they did.

The phrase “generational turnover” has become, on Immortality Earth, almost entirely theoretical.

This has effects that compound. Organizations calcify around the preferences and blind spots of whoever was in charge when the music stopped. Industries develop a conservatism born not of wisdom but of the simple fact that the people making decisions have been making similar decisions for decades and have, without quite noticing, stopped being able to imagine doing things differently. Young professionals — and “young” now stretches into your forties, given that you are competing against people who have been in their fields since before you were born — describe their career trajectories with a particular rueful specificity. There are positions they would like to hold that are currently held by people who are, biologically, forty-three, and who have no particular reason to leave.

The entry-level job, on Immortality Earth, can last a very long time.

There is a word for it in several languages. In English, the most common term is lifelock — the condition of being stuck, not through any failure of your own, but through the simple arithmetic of a world where the people ahead of you stopped clearing the way.

The Psychology Problem (The Hardest One)

This is where the sardonic tour-guide voice starts to fail, because what happens to a person who no longer has a natural ending is not, primarily, funny.

Therapists on Immortality Earth — and there are many of them, the mental health field being one of the few genuinely growth industries in a stagnant economy — have developed an extensive literature on what they call temporal disorientation: the psychological condition of a person whose relationship to time has been structurally altered in a way that their emotional architecture was not built to accommodate.

Human motivation, across its many forms, has always been quietly underwritten by scarcity. The scarcity of time, specifically. The knowledge that you have a limited number of years and that this limitation should probably inform your choices — what to pursue, what to abandon, who to love, what to forgive, when to begin something new, when to let something go. The urgency that makes a thing feel worth doing is, in most cases, traceable to the awareness that you will not always have the option.

Remove the scarcity and the urgency attenuates. Not immediately — the first generation to receive the treatment spent years in a state of elated relief, a collective exhale of not yet, not yet, we have more time. But the elation was built on contrast with a mortality they remembered, and contrast fades. The generation born after 1994 to parents who had already received the treatment grew up without mortality as a lived reference point, and their relationship to time is something that psychologists are still working to characterize and that the people experiencing it mostly describe as feeling like Sunday afternoon, specifically the part of Sunday afternoon when you know you should probably do something but can’t quite identify what.

There is a flatness to ambition on Immortality Earth. Not an absence of it — people still want things, still strive, still love and grieve and create. But the shape of wanting has changed. When you can always do it later, later has a way of becoming the default setting. When the horizon doesn’t move, the walk toward it changes character.

Dr. Chae, who is now seventy-one years old and biologically forty-four, has spoken about this in several long interviews conducted over the past decade. She is careful and precise and clearly a person of genuine conscience. She does not use the word “regret,” but she uses the word “unanticipated” quite a lot. She talks about the thing she was trying to solve — the suffering of people with chronic illness, the losses she had watched — and about the difficulty of standing in the present and drawing a clear line from that intention to this outcome.

She is working, she has said, on something new. She has been working on it for a while. There is, she acknowledges, no particular deadline.

What the Sliders Know

You will leave Immortality Earth having seen a world that got what it asked for. The suffering of death by aging has been eliminated. That was a real suffering, as real as any, and its elimination is not nothing. The people of this world do not miss it.

They miss other things. The sense that a year means something. The particular quality of attention paid to a thing you know you won’t have forever. The way a limited life forces, or used to force, a kind of editing — a choosing of what matters by the natural pressure of what must eventually be left behind.

Nobody dies of old age on Immortality Earth. They just wait. They wait in the waiting room of a civilization that has more people than room, more experience than opportunity, more time than it knows what to do with.

The cure worked. It worked completely and permanently and for nearly everyone.

It solved the problem it was designed to solve and in doing so quietly retired a thousand other things — urgency, momentum, the generative pressure of a life with edges — that nobody had thought to list as things worth keeping until they were already gone.

You will find yourself, sliding out, thinking about deadlines. Not with dread, exactly. With something closer to gratitude. The kind you only feel for a thing once you’ve seen a world that doesn’t have it.

---

Join me tomorrow for J — and another world waiting just beyond the edge of what we know.